期刊文献+

IgA肾病合并恶性高血压36例临床与病理分析 被引量:4

下载PDF
导出
摘要 目的:探讨IgA肾病合并恶性高血压的临床病理特点。方法:回顾性分析36例IgA肾病合并恶性高血压临床病例资料。结果:36例IgA肾病合并恶性高血压患者均表现为头晕,头痛,视力模糊;有隐匿性肾炎病史18例;镜下血尿25例,11例24 h尿蛋白定量>3.5g;病理表现大部分为肾小球系膜细胞增殖及系膜基质增宽,间质炎性细胞浸润明显,肾间质纤维化;治疗使用硝普纳或乌拉地尔降压治疗,血压控制满意后,行透析治疗或给予个体化治疗。21例血压控制到正常,有效9例(25%)。结论:对于有肾炎病史,年龄<40岁,尿蛋白>3.5 g/d,血液免疫学异常的患者,应高度怀疑为伴有恶性高血压的IgA肾病;病机是慢性肾小球病变加重基础上引起肾功能急剧恶化,直接导致肾脏和患者存活率大幅度下降,预后较差。
出处 《陕西医学杂志》 CAS 2011年第8期1022-1022,1044,共2页 Shaanxi Medical Journal
  • 相关文献

参考文献4

二级参考文献27

  • 1黎磊石,许顶立.高血压与肾脏专题座谈会纪要[J].中华内科杂志,1989,28(5):302-306. 被引量:6
  • 2黄庆元,赵从禄.IgA肾病56例分析—大量蛋白尿的特殊表现[J].中华肾脏病杂志,1989,5(1):11-14. 被引量:5
  • 3毕增祺 李学旺 等.IgA肾病40例临床病理分析[J].中华内科杂志,1984,23(3):136-136.
  • 4D'Amico G. Natural history of idiopathic IgA nephropathy:role of clinical and histological prognostic factors. Am J Kidney Dis, 2000, 36(2):227-237
  • 5Geddes CC, Rauta V, Gronhagen-Riska C, et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant, 2003, 18:1541-1548
  • 6Li TK, Ho KL, Szeto CC, et al. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant, 2002, 17:64-69
  • 7Donadio JV, Bergatralh EJ, Grande JP, et al. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant,2002, 17:1197-1203
  • 8D' Amico G, Minetti L, Ponticelli C, et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. QJ Med,1986, 59(228):363-378
  • 9Johnston PA, Brown JS, Braumholtz DA, et al. Clinicopathological correlations and long-term follow-up of 253United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. QJ Med, 1992,84(304):619-627
  • 10Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy:morphologic predictors of progressive renal disease. Hum Pathol, 1982, 13(4):314-322

共引文献43

同被引文献32

  • 1王少华,张红霞,卢志远,等.血尿康胶囊治疗IgA肾病血尿的临床疗效观察[J].国中西医结合肾病杂志,2012,8(13):730-732.
  • 2沈琪,欧阳小林,黄献文,等.抗高血压类药物治疗IgA肾病的Meta分析[J].中国全科医生,2013,16(3):904-910.
  • 3Redon J, Plancha E, Swift PA, et al. Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4 [J].J Hypertens,2010,28(1):602-607.
  • 4张伟,张道友,顾德明,等.107例肾活检临床与病理分析.安徽省医学会肾脏病学分会2012年学术年会论文集,2012:169.
  • 5Shi SF, Wang SX, Jiang L, et al. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy:validation of the Oxford classification [ J ]. Clin J Am Soc Nephrol, 2011,6 : 2175 -2184.
  • 6Liu L, Li GT, Zhou Y, et al. Clinicopathologie features and out- comes in endocapiIlary proliferative IgA nephropathy [ J ]. Neph- ron Clin Pract ,2010,115 (2) : 161-167.
  • 7Tissandie E, Morelle W, Berthelot L, et al. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes:Common mechanisms for distinct diseases[ J]. Kidney Int,2011,80( 12 ) : 1352-1365.
  • 8Walsh M, Sat A, lee D, et al. I-Iistopathologic features aid in pre- dicting risk for progression of IgA nephropathy [ J ]. Clin J Am Soc Nephrol,2011,5(3) :425-430.
  • 9沈庆法.隐匿性肾小球肾炎的中西医诊治[J].中国临床医生杂志,2010,38(7):64-66. 被引量:3
  • 10徐永庆,王新锋.尿足状突细胞标志蛋白、血清胱抑素C在无症状蛋白尿患者中的临床研究[J].医学检验与临床,2010(5):89-91. 被引量:3

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部